we randomized 158 recipients of cadaver renal allografts to cyclosporine-prednisone ( 83 ) or antilymphocyte globulin-azathioprine-prednisone ( 75 ) to evaluate : the effects of immunosuppression and pretransplant risk factors on the incidence of delayed graft function , the effects of immunosuppression on the resolution of delayed graft function , and the effects of delayed graft function and pretransplanted risk factors on patient and graft survival .
C0338291
cyclosporine-prednisone
C0032952
prednisone